The present invention relates to inhalable microparticles for systemic delivery. Specifically, thepresent invention relates to a formulation comprising inhalable microparticles ofHydroxychloroquine and surfactant. The present invention further relates to a process forpreparing the formulation comprising inhalable microparticles of Hydroxychloroquine andsurfactant based on quasi-emulsification solvent evaporation technique followed by freeze10 drying. The present invention also provides a method for the management of Acute RespiratorySyndrome associated with COVID and viral morbidities comprising administeringpharmaceutically effective amount of inhalable microparticles.
SANDEEP ARORA, SUKHBIR SINGH, NEELAM SHARMA